Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Operating Expenses: 2019-2025

Historic Other Operating Expenses for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $29.5 million.

  • Harmony Biosciences Holdings' Other Operating Expenses rose 7.15% to $29.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year increase of 7.02%. This contributed to the annual value of $110.9 million for FY2024, which is 13.87% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Other Operating Expenses stood at $29.5 million, which was down 1.74% from $30.1 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Other Operating Expenses registered a high of $30.7 million during Q1 2025, and its lowest value of $15.5 million during Q1 2021.
  • Moreover, its 3-year median value for Other Operating Expenses was $27.6 million (2024), whereas its average is $27.2 million.
  • Data for Harmony Biosciences Holdings' Other Operating Expenses shows a peak YoY skyrocketed of 36.80% (in 2021) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Other Operating Expenses (Quarterly) stood at $19.1 million in 2021, then grew by 10.29% to $21.1 million in 2022, then grew by 27.57% to $26.9 million in 2023, then grew by 2.66% to $27.6 million in 2024, then increased by 7.15% to $29.5 million in 2025.
  • Its Other Operating Expenses was $29.5 million in Q3 2025, compared to $30.1 million in Q2 2025 and $30.7 million in Q1 2025.